Net profit of Tatva Chintan Pharma Chem declined 89.28% to Rs 1.03 crore in the quarter ended March 2025 as against Rs 9.61 crore during the previous quarter ended March 2024. Sales rose 9.76% to Rs 107.86 crore in the quarter ended March 2025 as against Rs 98.27 crore during the previous quarter ended March 2024.
For the full year,net profit declined 81.19% to Rs 5.71 crore in the year ended March 2025 as against Rs 30.35 crore during the previous year ended March 2024. Sales declined 2.74% to Rs 382.71 crore in the year ended March 2025 as against Rs 393.50 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 107.86 | 98.27 | 10 | 382.71 | 393.50 | -3 |
| OPM % | 8.30 | 15.88 | - | 8.94 | 17.33 | - |
| PBDT | 9.29 | 19.92 | -53 | 35.24 | 69.17 | -49 |
| PBT | 2.03 | 13.69 | -85 | 7.58 | 43.57 | -83 |
| NP | 1.03 | 9.61 | -89 | 5.71 | 30.35 | -81 |